Search | Page 20 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes

    ... Associated Drug(s):  Azacitidine Phase:  Phase 2 ... Intervention:  Drug: CC-486 (ORAL AZACITIDINE) 200 mg CC-486 (Oral Azacitidine) will be given for the first 21 ...

    Clinical Trial last updated 04/19/2016 - 12:22pm.

  2. Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant (ICT-HCT)

    ... Associated Drug(s):  Azacitidine Decitabine Phase:  ... Intervention:  Drug: Azacitidine Given IV or SC Other Names: 5 ...

    Clinical Trial last updated 04/27/2016 - 9:41am.

  3. Evaluation of RUX and AZA Combination as a Therapy For Patients With Myelofibrosis And Myelodysplastic Syndrome/ Myeloproliferative Neoplasm

    ... Associated Drug(s):  Azacitidine Phase:  Phase 2 ... 1, 2 and 3. Other Names: Jakafi INCB018424 INC424 Drug: Azacitidine (AZA) Four weeks (28 days) on therapy is considered one standard ...

    Clinical Trial last updated 04/28/2016 - 1:56pm.

  4. MDS - Treatment (OLD)

    ... to specifically treat MDS in the U.S. These include azacitidine (Vidaza®) and decitabine (Dacogen®), both considered ...

    Topic section last updated 03/10/2016 - 11:01pm.

  5. A Phase II Study of 5-Azacitidine and Sargramostim as Maintenance Treatment After Definitive Therapy for Poor-risk AML or MDS

    ... Associated Drug(s):  Azacitidine Phase:  Phase 2 ... Intervention:  Drug: 5-azacitidine and sargramostim 5-azacitidine will be administered days 1-5 of a ...

    Clinical Trial last updated 05/03/2016 - 10:38am.

  6. Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS (UPCI 13-165)

    ... Associated Drug(s):  Azacitidine Phase:  Phase 2 ...

    Clinical Trial last updated 04/29/2016 - 10:26am.

  7. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... Alemtuzumab Azacitidine Fludarabine Phase:  ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  8. A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

    ... Associated Drug(s):  Azacitidine Phase:  Phase 2 ...

    Clinical Trial last updated 04/27/2016 - 9:37am.

  9. Clinical Trials Report for November 2015

    ... Efficacy and Safety Study of CC-486 (ORAL AZACITIDINE) in Subjects With Myelodysplastic Syndromes The primary ... study is to Evaluate the efficacy and safety of CC-486 (ORAL AZACITIDINE) in subjects with myelodysplastic syndromes. This study is ...

    Page last updated 10/30/2015 - 8:46am.

  10. Clinical Trials Report for October 2015

    ... Efficacy and Safety Study of CC-486 (ORAL AZACITIDINE) in Subjects With Myelodysplastic Syndromes The primary ... study is to Evaluate the efficacy and safety of CC-486 (ORAL AZACITIDINE) in subjects with myelodysplastic syndromes. This study is ...

    Page last updated 09/30/2015 - 10:53am.